MétaCan
Menu
Back to cohort
Record W2577681251 · doi:10.1038/onc.2016.482

Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality

2017· article· en· W2577681251 on OpenAlexaff
Brian Wan-Chi Tse, Marianna Volpert, Ellca Ratther, Nataly Stylianou, Mannan Nouri, K McGowan, Melanie Lehman, Stephen J. McPherson, Mani Roshan‐Moniri, Miriam Butler, Josselin Caradec, Cheryl Y. Gregory‐Evans, Jacqui McGovern, Rajdeep Das, Mandeep Takhar, Nicholas Erho, Mohamed Alshalafa, Elai Davicioni, Edward M. Schaeffer, Robert B. Jenkins, Ashley E. Ross, R. Jeffrey Karnes, Robert B. Den, Ladan Fazli, Philip A. Gregory, Martin Gleave, Elizabeth D. Williams, Paul S. Rennie, Ralph Buttyan, Jennifer H. Gunter, Luke A. Selth, Pamela J. Russell, Colleen C. Nelson, Brett G. Hollier

Bibliographic record

VenueOncogene · 2017
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicAngiogenesis and VEGF in Cancer
Canadian institutionsGenome British ColumbiaUniversity of British Columbia
FundersProstate Cancer Foundation of AustraliaQueensland GovernmentQueensland HealthMovember FoundationCure Cancer Australia FoundationAustralian GovernmentCancer AustraliaProstate Cancer Foundation
KeywordsProstate cancerCancer researchMetastasisNeuropilin 1AngiogenesisBiologyTumor progressionEnzalutamideCancerAndrogen receptorProstateOncologyInternal medicineMedicineVascular endothelial growth factor

Abstract

fetched live from OpenAlex

Recent evidence has implicated the transmembrane co-receptor neuropilin-1 (NRP1) in cancer progression. Primarily known as a regulator of neuronal guidance and angiogenesis, NRP1 is also expressed in multiple human malignancies, where it promotes tumor angiogenesis. However, non-angiogenic roles of NRP1 in tumor progression remain poorly characterized. In this study, we define NRP1 as an androgen-repressed gene whose expression is elevated during the adaptation of prostate tumors to androgen-targeted therapies (ATTs), and subsequent progression to metastatic castration-resistant prostate cancer (mCRPC). Using short hairpin RNA (shRNA)-mediated suppression of NRP1, we demonstrate that NRP1 regulates the mesenchymal phenotype of mCRPC cell models and the invasive and metastatic dissemination of tumor cells in vivo. In patients, immunohistochemical staining of tissue microarrays and mRNA expression analyses revealed a positive association between NRP1 expression and increasing Gleason grade, pathological T score, positive lymph node status and primary therapy failure. Furthermore, multivariate analysis of several large clinical prostate cancer (PCa) cohorts identified NRP1 expression at radical prostatectomy as an independent prognostic biomarker of biochemical recurrence after radiation therapy, metastasis and cancer-specific mortality. This study identifies NRP1 for the first time as a novel androgen-suppressed gene upregulated during the adaptive response of prostate tumors to ATTs and a prognostic biomarker of clinical metastasis and lethal PCa.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.138
Threshold uncertainty score0.329

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.024
GPT teacher head0.310
Teacher spread0.286 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations92
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueOncogeneSame topicAngiogenesis and VEGF in CancerFrench-language works237,207